Skip to main content

Multiparametric imaging of glioblastoma tumour heterogeneity for supporting treatment decisions and accurate prognostic estimation

Project description

AI-based multiparametric imaging of glioblastoma for a personalised treatment strategy

Glioblastoma is the most frequent and aggressive malignant tumour of the central nervous system. Tumour heterogeneity is the major factor responsible for the disease's high mortality rate and resistance to effective treatment. The EU-funded GLIOHAB project will develop an artificial intelligence-based system with the ability to monitor the functional state of the glioblastoma at pixel level. The development of the software capitalises on technologies previously co-developed, validated and patented by the project researcher. GLIOHAB represents a multidisciplinary effort of the best experts to provide the optimum conditions for a holistic approach to glioblastoma treatment.


Net EU contribution
€ 214 158,72
Kirkeveien 166 Tarnbygget
0450 Oslo

See on map

Norge Oslo og Viken Oslo
Activity type
Higher or Secondary Education Establishments
Non-EU contribution
€ 0,00